secwatch.observer — SEC 8-K summary
======================================

Issuer:     Surgery Partners, Inc. (SGRY)
CIK:        0001638833
Form:       8-K
Filed at:   2023-05-01T23:59:59+00:00
Accession:  0001638833-23-000067
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Surgery Partners Q1 revenue up 11.7% to $666.2M, net loss $24.9M, raises 2023 EBITDA guidance >$430M
--------------------------------------------------------------------------------

- Revenue $666.2M (+11.7% YoY); same-facility revenue +10.3% (cases +5.3%, revenue per case +4.8%).
- Net loss attributable to SGRY $24.9M vs net income $12.2M in Q1 2022; Adjusted EBITDA $90.1M (+17% from $77.1M).
- Raises 2023 Adjusted EBITDA guidance to >$430M; Q1 free cash flow $20.5M, deployed $60M on five acquisitions.
- New strategic partnerships with Intermountain Health and OhioHealth for expansion in new markets.
- Net debt to EBITDA 4.3x; liquidity ~$800M ($245.5M cash + $545.9M revolver availability).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1638833/000163883323000067/0001638833-23-000067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1638833/000163883323000067/sgry-20230501.htm
  HTML page:      https://secwatch.observer/filing/0001638833-23-000067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer